136 related articles for article (PubMed ID: 37686093)
1. The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer.
Ji HZ; Liu B; Ren M; Li S; Zheng JF; Liu TY; Yu HH; Sun Y
Expert Rev Clin Immunol; 2024 May; 20(5):559-569. PubMed ID: 38224014
[TBL] [Abstract][Full Text] [Related]
2. Biophysical characterization of the CXC chemokine receptor 2 ligands.
Martin P; Kurth EA; Budean D; Momplaisir N; Qu E; Simien JM; Orellana GE; Brautigam CA; Smrcka AV; Haglund E
PLoS One; 2024; 19(4):e0298418. PubMed ID: 38625857
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors.
Korbecki J; Bosiacki M; Szatkowska I; Kupnicka P; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673949
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy-An Integrated View into Other Neoplasms and Chemokine Networks.
Filimon A; Preda IA; Boloca AF; Negroiu G
Cells; 2021 Dec; 11(1):. PubMed ID: 35011682
[TBL] [Abstract][Full Text] [Related]
5. CXCL3: A key player in tumor microenvironment and inflammatory diseases.
Bao Y; Tong C; Xiong X
Life Sci; 2024 May; 348():122691. PubMed ID: 38714265
[TBL] [Abstract][Full Text] [Related]
6. Perspective from single-cell sequencing: Is inflammation in acute ischemic stroke beneficial or detrimental?
Deng X; Hu Z; Zhou S; Wu Y; Fu M; Zhou C; Sun J; Gao X; Huang Y
CNS Neurosci Ther; 2024 Jan; 30(1):e14510. PubMed ID: 37905592
[TBL] [Abstract][Full Text] [Related]
7. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer.
Korbecki J; Kupnicka P; Chlubek M; Gorący J; Gutowska I; Baranowska-Bosiacka I
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216283
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes.
Korbecki J; Bosiacki M; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686093
[TBL] [Abstract][Full Text] [Related]
10. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
[TBL] [Abstract][Full Text] [Related]
11. Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization.
Boon K; Vanalken N; Szpakowska M; Chevigné A; Schols D; Van Loy T
Cell Commun Signal; 2024 Jan; 22(1):43. PubMed ID: 38233929
[TBL] [Abstract][Full Text] [Related]
12. The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.
Lüttichau HR
J Biol Chem; 2010 Mar; 285(12):9137-46. PubMed ID: 20044480
[TBL] [Abstract][Full Text] [Related]
13. A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis.
Zhou Z; Xia G; Xiang Z; Liu M; Wei Z; Yan J; Chen W; Zhu J; Awasthi N; Sun X; Fung KM; He Y; Li M; Zhang C
Clin Cancer Res; 2019 Jun; 25(11):3317-3328. PubMed ID: 30796034
[TBL] [Abstract][Full Text] [Related]
14. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
Dong YL; Kabir SM; Lee ES; Son DS
PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
